Markets:

Overview

News

Currencies

International

Treasuries

Bionano Genomics, Inc. - Common Stock (NQ:BNGO)

1.594 +0.034 (+2.21%)

Delayed Quote Updated: 10:57 AM EDT, Oct 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bionano Genomics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Bionano Genomics Has Attractive Applications But An Unattractive Stock Price ↗

February 24, 2022

BNGO stock will witness more hard times until profitability is improved and sales start to rebound. That could take some time.

Via InvestorPlace

Bionano Stock Looks to Have a Monster Comeback in Its Future ↗

February 17, 2022

Bionano's Saphyr appears to be able to help doctors treat leukemia, and the adoption of its device is growing rapidly.

Via InvestorPlace

Investors Have Cast Their ‘No’ Votes Against Bionano Genomics ↗

February 07, 2022

A preliminary report from Bionano Genomics doesn't tell the full story and a lack of profitability will likely weigh on BNGO stock.

Via InvestorPlace

Bionano Is Not the Genomics Stock To Bet On ↗

February 04, 2022

Bionano's recent results are lackluster and point to more volatility ahead for BNGO stock. Best to just avoid this stock for now.

Via InvestorPlace

Bionano Genomics Is Interesting as Genome Testing Scales Upwards ↗

January 25, 2022

BNGO Stock is a play in the burgeoning gene sequencing market at scale, not at home. That's worth understanding and potentially purchasing.

Via InvestorPlace

Bionano Genomics Preliminary Q4, FY21 Revenue Exceed Expectations ↗

January 12, 2022

Bionano Genomics Inc (NASDAQ: BNGO) posted preliminary Q4 sales of $5.8 million - $6.2 million, +25% - 33% sequentially, up 45% - 55% Y/Y, and above the consensus...

Via Benzinga

7 of the Best Cheap Stocks Under $10 for 2022 to Buy Now ↗

January 06, 2022

These cheap stocks under $10 are poised to rally in the new, more friendly macro environment that's in place as 2022 unfolds.

Via InvestorPlace

Bionano Genomics Stock Is a Low-Priced Bet on Sound Science ↗

January 03, 2022

Even though BNGO stock investors struggled in 2021, prepare for new price discovery as Bionano pushes the envelope in optical genome mapping.

Via InvestorPlace

The Critics Are Wrong About Bionano Stock ↗

December 27, 2021

The critics of Bionano are greatly underestimating the vast potential of Saphyr and of BNGO stock for long-term investors.

Via InvestorPlace

This Analyst’s Saphyr Calculations Suggest Buying Bionano While It’s Down ↗

December 14, 2021

If BNGO stock reaches Oppenheimer’s price target, investors are looking at a return of more than 300%, plus long-term growth potential.

Via InvestorPlace

5 Penny Stocks Insiders Are Buying ↗

December 01, 2021

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and ...

Via Benzinga

Bionano Genomics Proves Not Everything Genetic is Gold ↗

December 01, 2021

Bionano sells a $150,000 machine called Saphyr that does genetic mapping. It's a solid device, but its future remains in the future, as do BNGO stock fortunes.

Via InvestorPlace

Jim Cramer Shares His Thoughts On Chegg, Bristol-Myers Squibb And More ↗

November 30, 2021

On CNBC’s "Mad Money Lightning Round," Jim Cramer said with Matterport, Inc. (NASDAQ:

Via Benzinga

Wait for Bionano Stock to Fall Further Before Buying ↗

November 23, 2021

BNGO stock is breaking down following the latest earnings report, and there are no major catalysts to push shares up in the short term.

Via InvestorPlace

Bionano’s Is on Track for Growth Thanks to Saphyr ↗

November 19, 2021

BNGO stock beats analyst forecasts yet again. Flush with cash and with Saphyr installations rising, this stock remains a high potential play.

Via InvestorPlace

With Progress on Multiple Fronts, Bionano Genomics Stock Is Great Buy Here ↗

November 12, 2021

Bionano's acquisition of a software company makes Saphyr more attractive, and studies should result in insurers reimbursing those who use the system. BNGO stock is a buy.

Via InvestorPlace

Bionano Genomics, Inc (BNGO) Q3 2021 Earnings Call Transcript ↗

November 06, 2021

BNGO earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO ↗

November 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 02, 2021

Gainers Kiniksa Pharmaceuticals (NASDAQ:KNSA) stock increased by 16.73% to $14.86 during Tuesday's regular session. The current volume of 1.0 million shares is 269.7%...

Via Benzinga

2 Best Biotech Stocks to Buy in November ↗

November 01, 2021

Bionano Genomics and Ocugen could both be gearing up for a healthy rally this month.

Via The Motley Fool

Bionano Genomics Is Still Set to Pay Off Big for Patient Investors ↗

October 28, 2021

BNGO stock is no longer a fast money trade. But that's hardly a reason to skip out on it, given its massive potential.

Via InvestorPlace

Jim Cramer Prefers This Stock Over Mogo, Considers Endeavor Group As Inexpensive ↗

October 19, 2021

On CNBC’s "Mad Money Lightning Ro...

Via Benzinga

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

Bionano Genomics’ Latest Software Business Acquisition Adds Immense Value ↗

October 19, 2021

BNGO stock isn't a darling of the markets at the moment, but Bionano continues to advance its stature in the optical genome mapping niche.

Via InvestorPlace

Bionano Genomics Stock Looks Ready to Reward Patient Investors ↗

October 18, 2021

BNGO stock is down 25% since year to date. But as the company begins to deliver consistent revenue, a prudent investment may be rewarded.

Via InvestorPlace

What's Up With Bionano Genomics Today? ↗

October 12, 2021

Bionano Genomics Inc. (NASDAQ: BNGO) shares are trading higher Tuesday after the company announced it agreed to buy BioDiscovery Inc, a provider of software for analysis,...

Via Benzinga

BNGO Stock: The Big Acquisition News Sending Bionano Genomics Soaring ↗

October 12, 2021

Bionano has just made a deal that will help it secure a spot among biotech companies riding the wave of the current boom. BNGO stock is up.

Via InvestorPlace

Groundbreaking Tech Makes Bionano Genomics Look Better Than Ever ↗

October 07, 2021

Off and on the price chart, Bionano Genomics could be the next big thing in genomics with multiple catalysts for BNGO stock.

Via InvestorPlace

BNGO Stock: What Is Driving Bionano Genomics Higher Today? ↗

September 30, 2021

Today, investors in Bionano Genomics and BNGO stock are cheering some positive clinical trial data around optical genome mapping.

Via InvestorPlace

Bionano Genomics Remains Promising With Global Product Adoption ↗

September 21, 2021

BNGO stock has been stuck in a range, but its next move should be to the upside based on Bionano's breakthrough genome mapping system.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.